Interpace Biosciences, Inc. (IDXG)
OTCMKTS · Delayed Price · Currency is USD
1.100
-0.040 (-3.51%)
Oct 29, 2025, 4:00 PM EDT

Interpace Biosciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Oct '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
512543113
Upgrade
Market Cap Growth
-27.10%152.98%5.76%-85.77%145.72%-33.55%
Upgrade
Enterprise Value
86360588753
Upgrade
Last Close Price
1.102.701.081.047.473.14
Upgrade
PE Ratio
7.141.902.40---
Upgrade
PS Ratio
0.110.250.120.140.940.39
Upgrade
PB Ratio
-4.01-5.35-0.52-0.277.570.73
Upgrade
P/FCF Ratio
1.163.151.41---
Upgrade
P/OCF Ratio
0.962.561.24---
Upgrade
EV/Sales Ratio
0.171.351.491.822.621.63
Upgrade
EV/EBITDA Ratio
1.117.5511.97---
Upgrade
EV/EBIT Ratio
1.317.8315.07---
Upgrade
EV/FCF Ratio
1.7916.8418.00---
Upgrade
Debt / Equity Ratio
-2.60-2.64-1.24-0.972.600.27
Upgrade
Debt / EBITDA Ratio
0.470.641.93-34.59-
Upgrade
Debt / FCF Ratio
0.751.553.37---
Upgrade
Asset Turnover
3.593.362.751.170.790.67
Upgrade
Inventory Turnover
15.4313.9512.2213.289.9511.18
Upgrade
Quick Ratio
1.080.940.750.690.470.59
Upgrade
Current Ratio
1.331.110.910.850.780.78
Upgrade
Return on Equity (ROE)
-----65.25%-133.86%
Upgrade
Return on Assets (ROA)
28.27%36.32%17.03%-8.82%-8.57%-30.83%
Upgrade
Return on Capital (ROIC)
-173.90%284.05%-33.34%-19.45%-58.78%
Upgrade
Return on Capital Employed (ROCE)
110.40%194.10%235.90%---
Upgrade
Earnings Yield
84.32%56.45%41.64%-494.86%-47.92%-208.43%
Upgrade
FCF Yield
86.44%31.75%70.72%-180.61%-29.10%-122.56%
Upgrade
Buyback Yield / Dilution
-521.84%-260.54%-2.97%-2.49%-2.63%-7.56%
Upgrade
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.